In this study, we used TCGA and GEO databases to screen and identify GPR related gene signatures closely related to the prognosis of bladder cancer, explore their interaction with bladder urothelial carcinoma (BLCA) immune microenvironment, and use this gene signatures to predict the response of BLCA to immunotherapy. Here, ALDH18A1 is linked to urinary bladder cancer.